Trial intelligence / Profile preview

Carvedilol for Cocaine Dependence

NCT01171183Phase 2Completed

Sponsor
University of Arkansas
Start
Aug 2010
Primary completion
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cocaine dependence comparing Carvedilol with Placebo (2 arms). Primary endpoint: Urine Toxicology Screens at 10 weeks. Started Aug 2010; status: completed.

02

Drugs

carvedilol
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT01171183.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01171183.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call